Peripheral intake of the acetylcholinesterase antagonist physostigmine causes symptoms of anxiety and depression in humans by decreasing the breakdown of ACh and increasing levels of the neurotransmitter in the brain (52). Here, ACHE is linked to depressive symptom measurement.